We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EFOR:BISTEfor Yatirim Sanayi Ticaret A.S. Analysis

Data as of 2026-07-16 - not real-time

$17.26

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Everforth, Inc. (EFOR) trades around $17.26, well below its DCF‑derived fair value of roughly $52, implying an upside of over 50% and a valuation grade of *undervalued*. The stock’s trailing P/E of 7.6 is dramatically lower than the industry average of 34, and its price‑to‑book of 0.4 underscores the discount. However, technicals show a bearish bias: the price sits just above the 20‑day SMA (18.2) and below the 50‑day SMA (19.3), with a decreasing volume trend, a high 30‑day volatility of 75%, and a recent max drawdown of nearly 70%. The MACD line has crossed above its signal, offering a faint bullish signal, while the RSI at 42 suggests limited momentum.
Analyst sentiment has softened to a “Hold” rating after an upgrade from Underperform, with a median price target near $27.5, still far below the DCF estimate. The company generates modest cash flow, carries a high debt‑to‑equity ratio (≈86%), and pays no dividend, highlighting a focus on growth reinvestment rather than income. Investors must weigh the deep valuation gap against the steep recent price decline and elevated risk metrics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support level with limited upside in the near term
  • Bearish trend and high short‑term volatility
  • Decreasing volume indicating reduced market participation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Substantial valuation upside relative to DCF and analyst targets
  • Low valuation multiples (P/E, P/B) compared with peers
  • Improving earnings outlook reflected in higher forward EPS

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular demand for IT services across commercial and federal segments
  • Strong operating and free cash flow generation
  • Attractive balance‑sheet leverage if debt is managed and earnings grow

Key Metrics & Analysis

Financial Health

Profit Margin2.46%
P/E Ratio7.6
ROE5.48%
ROA4.07%
Debt/Equity85.62
P/B Ratio0.4
Op. Cash Flow$329.6M
Free Cash Flow$270.1M
Industry P/E34.0

Technical Analysis

TrendBearish
RSI42.0
Support$16.90
Resistance$21.51
MA 20$18.24
MA 50$19.32
MA 200$37.52
MACDBullish
VolumeDecreasing
Fear & Greed Index93.45

Valuation

Fair Value$51.75
Target Price$27.33
Upside/Downside58.36%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.76
Volatility75.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.